A5038089288- Pancreatic and Hepatic Oncology Research
- Pancreatitis Pathology and Treatment
- Gallbladder and Bile Duct Disorders
- Microscopic Colitis
- Helicobacter pylori-related gastroenterology studies
- Inflammatory Bowel Disease
- Pediatric Hepatobiliary Diseases and Treatments
- Eosinophilic Esophagitis
- Liver Disease Diagnosis and Treatment
- Neuroendocrine Tumor Research Advances
- Hip disorders and treatments
- Historical Studies on Spain
- Diabetic Foot Ulcer Assessment and Management
- Respiratory and Cough-Related Research
- Genetic and Kidney Cyst Diseases
- Cholangiocarcinoma and Gallbladder Cancer Studies
- MRI in cancer diagnosis
- Appendicitis Diagnosis and Management
- Bone and Joint Diseases
- Biliary and Gastrointestinal Fistulas
- Herpesvirus Infections and Treatments
- Electromagnetic Simulation and Numerical Methods
- Gastrointestinal Tumor Research and Treatment
- Gastric Cancer Management and Outcomes
- Congenital Diaphragmatic Hernia Studies
Complejo Hospitalario Universitario de Santiago
2019-2025
Hospital Clínico Universitario de Valladolid
2024
Universidade de Santiago de Compostela
2018-2023
Servicio Gallego de Salud
2023
Complexo Hospitalario Universitario A Coruña
2023
Instituto de Investigación Sanitaria de Santiago
2017-2022
Objective This study aimed to develop and validate a patient-reported outcome measure (PROM) in acute pancreatitis (AP) as an endpoint centred on the patient. Design A PROM instrument (PAtieNt-rePoRted OutcoMe scale pancreatItis, international proSpEctive cohort study, PAN-PROMISE scale) was designed based opinion of patients, professionals expert panel. The validated multicentre prospective describing severity AP quality life at 15 days after discharge main variables for validation. COSMIN...
Abstract Background Background: The feasibility of anti-TNF discontinuation in inflammatory bowel disease (IBD) must be proven clinical trials including patients clinical, endoscopic, and radiologic remission at the time withdrawal to make recommendations for practice. Aims Primary: compare rates 1 year who discontinue treatment vs. those continue treatment. Secondary objectives: know effect on relapse-free time, mucosal healing safety; identify predictive factors relapse. Methods...
Background and objectives Primary objectives: to compare the rates of sustained clinical remission at 12 months in patients treated with antitumour necrosis factor (anti-TNF) immunomodulators who withdraw anti-TNF treatment versus those maintain it. Secondary evaluate effect withdrawal on relapse-free time, endoscopic radiological activity, safety, quality life work productivity; identify predictive factors for relapse. Design Prospective, quadruple-blind, multicentre, randomised, controlled...
Aims: Primary: to compare the rates of clinical remission at 12 months in patients treated with anti-TNF and immunomodulators who withdraw treatment vs. those maintain it. Secondary objectives: evaluate effect withdrawal on relapse-free time, endoscopic radiologic activity, safety, quality life, work productivity; identify predictive factors for relapse.Methods: Prospective, quadruple-blind, multicentre, randomised, controlled trial. Patients ulcerative colitis or Crohn’s disease >6 absence...
Endoscopic ultrasound (EUS) was first described in 1986, with the aim of overcoming problems affecting transabdominal imaging, mainly related to interposition gas, and artifacts produced by bone or fat. Now, EUS can be considered as best method for analysis pancreatic diseases, overtaking diagnostic accuracy computed tomography magnetic resonance imaging. However, fundamental B-mode imaging is limited diagnosis solid lesions, because most them are depicted heterogeneous hypo-echoic, it...